 Connor Clark Lunn Investment Management Ltd. boosted its stake in Aldeyra Therapeutics, Inc NASDAQ:ALDX by 11.4 in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 99,722 shares of the biotechnology companys stock after purchasing an additional 10,225 shares during the quarter. Connor Clark ... 